New Zealand - Hospital Average Length of Stay for Hyperplasia of Prostate
Since 2014, New Zealand Hospital Average Length of Stay for Hyperplasia of Prostate was down by 0.6% year on year. In 2019, the country was number 23 comparing other countries in Hospital Average Length of Stay for Hyperplasia of Prostate at 3.1 Days. New Zealand is overtaken by Spain, which was ranked number 22 with 3.6 Days and is followed by Mexico at 2.8 Days. Lithuania lead the ranking with 6.1 Days in 2019, -1.6% compared to 2018. Slovenia witnessed the best average annual growth at +4.6% per year, while Netherlands recorded the worst performance at -6.8% per year.
Loading...
| Date | Days |
|---|---|
| 2019 | 3.10 |
| 2018 | 3.10 |
| 2017 | 3.10 |
| 2016 | 3.40 |
| 2015 | 3.60 |
Download all data from 2000 to 2019
How does New Zealand rank in Hospital Average Length of Stay for Hyperplasia of Prostate?
| # | 33 Countries | Days | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Lithuania
|
6.10 | 2019 | -1.6 % | -1.0 % | View data | |
| 1 |
#1
South Korea
|
6.10 | 2019 | -1.6 % | -1.0 % | View data | |
| 22 |
#22
Spain
|
3.60 | 2019 | -5.3 % | -3.0 % | View data | |
| 23 |
#23
New Zealand
|
3.10 | 2019 | +0.0 % | -0.6 % | View data | |
| 24 |
#24
Mexico
|
2.80 | 2019 | -3.5 % | -4.9 % | View data | |